UCB - stock earnings
UCB.BR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 32.0 million EUR | 2.7 billion EUR |
| 2023Q2 | 311.0 million EUR | 2.6 billion EUR |
| 2022Q4 | 19.0 million EUR | 2.6 billion EUR |
| 2022Q2 | 399.0 million EUR | 2.9 billion EUR |
| 2021Q4 | 487.0 million EUR | 3.0 billion EUR |
| 2020Q2 | 363.0 million EUR | 2.6 billion EUR |
| 2019Q4 | 380.0 million EUR | 2.6 billion EUR |
| 2019Q3 | 190.5 million EUR | 1.3 billion EUR |
| 2019Q2 | 203.5 million EUR | 1.2 billion EUR |
| 2019Q1 | 203.5 million EUR | 1.2 billion EUR |
| 2018Q4 | 203.5 million EUR | 1.2 billion EUR |
| 2018Q2 | 203.8 million EUR | 1.2 billion EUR |
| 2018Q1 | 200.0 million EUR | 1.2 billion EUR |
| 2017Q4 | 200.0 million EUR | 1.2 billion EUR |
| 2017Q3 | 161.0 million EUR | 1.2 billion EUR |
| 2017Q2 | 188.3 million EUR | 1.1 billion EUR |
| 2017Q1 | 188.3 million EUR | 1.1 billion EUR |
| 2016Q4 | 188.3 million EUR | 1.1 billion EUR |
| 2016Q3 | ? EUR | 1.1 billion EUR |
| 2016Q2 | 130.0 million EUR | 1.0 billion EUR |
| 2016Q1 | 130.0 million EUR | 1.0 billion EUR |
| 2015Q4 | 130.0 million EUR | 1.0 billion EUR |
| 2015Q3 | 155.8 million EUR | 969.0 million EUR |
| 2015Q2 | 155.8 million EUR | 969.0 million EUR |
| 2015Q1 | 155.8 million EUR | 969.0 million EUR |
| 2014Q4 | 155.8 million EUR | 969.0 million EUR |
| 2014Q3 | 52.3 million EUR | 836.0 million EUR |
| 2014Q2 | 52.3 million EUR | 836.0 million EUR |
| 2014Q1 | 52.3 million EUR | 836.0 million EUR |
| 2013Q4 | 52.3 million EUR | 836.0 million EUR |
| 2013Q3 | 51.8 million EUR | 852.8 million EUR |
| 2013Q2 | 51.8 million EUR | 852.8 million EUR |
| 2013Q1 | 51.8 million EUR | 852.8 million EUR |
| 2012Q4 | 51.8 million EUR | 852.8 million EUR |
| 2012Q3 | 64.0 million EUR | 865.5 million EUR |
| 2012Q2 | 64.0 million EUR | 865.5 million EUR |
| 2012Q1 | 64.0 million EUR | 865.5 million EUR |
| 2011Q4 | 64.0 million EUR | 865.5 million EUR |
| 2011Q3 | 58.8 million EUR | 811.5 million EUR |
| 2011Q2 | 58.8 million EUR | 811.5 million EUR |
| 2011Q1 | 58.8 million EUR | 811.5 million EUR |
| 2010Q4 | 58.8 million EUR | 811.5 million EUR |
| 2010Q3 | 26.0 million EUR | 804.5 million EUR |
| 2010Q2 | 26.0 million EUR | 804.5 million EUR |
| 2010Q1 | 26.0 million EUR | 804.5 million EUR |
| 2009Q4 | 26.0 million EUR | 804.5 million EUR |
| 2009Q3 | 128.5 million EUR | 779.0 million EUR |
| 2009Q2 | 128.5 million EUR | 779.0 million EUR |
| 2009Q1 | 128.5 million EUR | 779.0 million EUR |
| 2008Q4 | 128.5 million EUR | 779.0 million EUR |
| 2008Q3 | 10.8 million EUR | 900.3 million EUR |
| 2008Q2 | 10.8 million EUR | 900.3 million EUR |
| 2008Q1 | 10.8 million EUR | 900.3 million EUR |
| 2007Q4 | 10.8 million EUR | 900.3 million EUR |
| 2007Q3 | 40.3 million EUR | 906.5 million EUR |
| 2007Q2 | 40.3 million EUR | 906.5 million EUR |
| 2007Q1 | 40.3 million EUR | 906.5 million EUR |
| 2006Q4 | 40.3 million EUR | 906.5 million EUR |
| 2006Q3 | 91.8 million EUR | 630.8 million EUR |
| 2006Q2 | 91.8 million EUR | 630.8 million EUR |
| 2006Q1 | 91.8 million EUR | 630.8 million EUR |
| 2005Q4 | 91.8 million EUR | 630.8 million EUR |
| 2005Q3 | 188.8 million EUR | 585.3 million EUR |
| 2005Q2 | 188.8 million EUR | 585.3 million EUR |
| 2005Q1 | 188.8 million EUR | 585.3 million EUR |
| 2004Q4 | 188.8 million EUR | 585.3 million EUR |
| 2004Q3 | 90.8 million EUR | 883.5 million EUR |
| 2004Q2 | 90.8 million EUR | 883.5 million EUR |
| 2004Q1 | 90.8 million EUR | 883.5 million EUR |
| 2003Q4 | 90.8 million EUR | 883.5 million EUR |
| 2003Q3 | 84.9 million EUR | 831.9 million EUR |
| 2003Q2 | 84.9 million EUR | 831.9 million EUR |
| 2003Q1 | 84.9 million EUR | 831.9 million EUR |
| 2002Q4 | 84.9 million EUR | 831.9 million EUR |
| 2002Q3 | 83.0 million EUR | 1.4 billion EUR |
| 2002Q2 | 83.0 million EUR | 1.4 billion EUR |
| 2002Q1 | 83.0 million EUR | 1.4 billion EUR |
| 2001Q4 | 83.0 million EUR | 1.4 billion EUR |
UCB.BR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 343.0 million EUR | 5.3 billion EUR |
| 2022 | 418.0 million EUR | 5.5 billion EUR |
| 2021 | 1.1 billion EUR | 5.8 billion EUR |
| 2020 | 732.0 million EUR | 5.3 billion EUR |
| 2019 | 792.0 million EUR | 4.9 billion EUR |
| 2018 | 800.0 million EUR | 4.6 billion EUR |
| 2017 | 753.0 million EUR | 4.5 billion EUR |
| 2016 | 520.0 million EUR | 4.2 billion EUR |
| 2015 | 623.0 million EUR | 3.9 billion EUR |
| 2014 | 209.0 million EUR | 3.3 billion EUR |
| 2013 | 207.0 million EUR | 3.4 billion EUR |
| 2012 | 256.0 million EUR | 3.5 billion EUR |
| 2011 | 235.0 million EUR | 3.2 billion EUR |
| 2010 | 104.0 million EUR | 3.2 billion EUR |
| 2009 | 514.0 million EUR | 3.1 billion EUR |
| 2008 | 43.0 million EUR | 3.6 billion EUR |
| 2007 | 161.0 million EUR | 3.6 billion EUR |
| 2006 | 367.0 million EUR | 2.5 billion EUR |
| 2005 | 755.0 million EUR | 2.3 billion EUR |
| 2004 | 363.0 million EUR | 3.5 billion EUR |
| 2003 | 339.7 million EUR | 3.3 billion EUR |
| 2002 | 331.8 million EUR | 5.6 billion EUR |
| 2001 | ? EUR | 2.5 billion EUR |
| 2000 | ? EUR | 2.2 billion EUR |
UCB.BR
Price: €123
52 week price:
Dividend Yield: 0.01%
5-year range yield:
Forward Dividend Yield: 1.11%
Payout Ratio: 77.27%
Payout Ratio Range:
Dividend Per Share: 1.36 EUR
Earnings Per Share: 1.76 EUR
P/E Ratio: 50.67
Exchange: BRU
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 21.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 2.33%